LinkedInYouTubeFacebookInstagramTwitter

About Dr. Andrea Love

Andrea received her PhD in Immunology and Microbiology from New York Medical College. Her research focused on immune cell signaling and activation in the context of infectious disease, with particular emphasis on differential host-pathogen interactions. She joined Nexcelom in 2014 as a Field Applications Scientist, and currently serves as a Senior Business Development Manager, providing subject-matter expertise in the immunology and immuno-oncology research areas.
LinkedIn

Using Deep Machine Learning to Enhance Monoclonal Cell Line Identification

Monoclonal cell culture is critical for many research areas however, the process to establish monoclonal cell lines is time-consuming, and many methods used to monitor monoclonality of cell culture still rely on manual and low-throughput methods.

By |2021-06-15T04:05:55+00:00February 10th, 2021|Categories: Bioprocessing/Cell Live Development, Celigo, Instrument, Latest News|Tags: , , , , , , |0 Comments
Read More

Immunotherapy: the future of science and medicine?

Immunotherapy is a diverse and broad catch-all for any treatments and therapies that utilize the patient’s own immune response to mount a defense.

By |2021-06-15T04:23:08+00:00February 12th, 2020|Categories: Celigo, Immunology, Instrument, Latest News|Tags: , , |2 Comments
Read More
Nexcelom Bioscience LLC. | 360 Merrimack Street, Suite 200 | Lawrence, MA 01843 USA Telephone: +1 978.327.5340 or +44 (0) 161 232 4593 | Fax: 978.327.5341 (USA only) | Email: info@nexcelom.com | UK Office: Unit 5, Rutherford House, Pencroft Way | Manchester Science Park, Manchester M15 6SZ | www.nexcelom.com © 2003-2021 Nexcelom Bioscience LLC. All Rights Reserved. Nexcelom products are for RESEARCH USE ONLY and are not approved for diagnostic or therapeutic use.
LinkedInYouTubeFacebookInstagramTwitter
Go to Top